318 related articles for article (PubMed ID: 15006266)
21. Oral misoprostol vs. vaginal gemeprost prior to surgical termination of pregnancy in nulliparae.
Celentano C; Prefumo F; Di Andrea O; Presti F; Di Nisio Q; Rotmensch S
Acta Obstet Gynecol Scand; 2004 Aug; 83(8):764-8. PubMed ID: 15255850
[TBL] [Abstract][Full Text] [Related]
22. A randomised comparison between sublingual, oral and vaginal route of misoprostol for pre-abortion cervical ripening in first-trimester pregnancy termination under local anaesthesia.
Saxena P; Sarda N; Salhan S; Nandan D
Aust N Z J Obstet Gynaecol; 2008 Feb; 48(1):101-6. PubMed ID: 18275580
[TBL] [Abstract][Full Text] [Related]
23. A randomized controlled comparison of sublingual and vaginal administration of misoprostol for cervical priming before first-trimester surgical abortion.
Hamoda H; Ashok PW; Flett GM; Templeton A
Am J Obstet Gynecol; 2004 Jan; 190(1):55-9. PubMed ID: 14749635
[TBL] [Abstract][Full Text] [Related]
24. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
Hamoda H; Ashok PW; Flett GM; Templeton A
BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
[TBL] [Abstract][Full Text] [Related]
25. Intracervical application of the nitric oxide donor isosorbide dinitrate for induction of cervical ripening: a randomised controlled trial to determine clinical efficacy and safety prior to first trimester surgical evacuation of retained products of conception.
Arteaga-Troncoso G; Villegas-Alvarado A; Belmont-Gomez A; Martinez-Herrera FJ; Villagrana-Zesati R; Guerra-Infante F
BJOG; 2005 Dec; 112(12):1615-9. PubMed ID: 16305563
[TBL] [Abstract][Full Text] [Related]
26. Misoprostol moistened with acetic acid or saline for second trimester pregnancy termination: a randomized prospective double-blind trial.
Yilmaz B; Kelekci S; Ertas IE; Kahyaoglu S; Ozel M; Sut N; Danisman N
Hum Reprod; 2005 Nov; 20(11):3067-71. PubMed ID: 16037107
[TBL] [Abstract][Full Text] [Related]
27. Different routes of misoprostol for cervical priming in first trimester surgical abortions: a randomized blind trial.
Ganer Herman H; Kerner R; Gluck O; Feit H; Keidar R; Bar J; Sagiv R
Arch Gynecol Obstet; 2017 Apr; 295(4):943-950. PubMed ID: 28255768
[TBL] [Abstract][Full Text] [Related]
28. First-trimester pregnancy termination with 800 microg of vaginal misoprostol every 12 h.
Salakos N; Kountouris A; Botsis D; Rizos D; Gregoriou O; Detsis G; Creatsas G
Eur J Contracept Reprod Health Care; 2005 Dec; 10(4):249-54. PubMed ID: 16448952
[TBL] [Abstract][Full Text] [Related]
29. Sublingual versus vaginal misoprostol for cervical dilatation 1 or 3 h prior to surgical abortion: a double-blinded RCT.
Sääv I; Kopp Kallner H; Fiala C; Gemzell-Danielsson K
Hum Reprod; 2015 Jun; 30(6):1314-22. PubMed ID: 25840429
[TBL] [Abstract][Full Text] [Related]
30. A comparison of vaginal misoprostol 800 microg versus 400 microg for anembryonic pregnancy: a randomized comparative trial.
Srikhao N; Tannirandorn Y
J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S41-7. PubMed ID: 17722316
[TBL] [Abstract][Full Text] [Related]
31. [Safety and efficacy of intravaginal misoprostol for cervical ripening in the third trimester of pregnancy].
Wang Z; Li W; Ouyang W
Zhonghua Fu Chan Ke Za Zhi; 1997 Jun; 32(6):326-8. PubMed ID: 9596908
[TBL] [Abstract][Full Text] [Related]
32. The use of oral misoprostol for pre-abortion cervical priming: a randomised controlled trial of 400 versus 200 microg in first trimester pregnancies.
Oppegaard KS; Abdelnoor M; Nesheim BI; Jerve F; Eskild A
BJOG; 2004 Feb; 111(2):154-9. PubMed ID: 14723753
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of 400 or 600 micrograms of vaginal misoprostol for terminations of early pregnancies.
Ruangchainikhom W; Phongphissanou E; Bhekasuta J; Sarapak S
J Med Assoc Thai; 2006 Jul; 89(7):928-33. PubMed ID: 16881422
[TBL] [Abstract][Full Text] [Related]
34. Sublingual misoprostol prior to manual vacuum aspiration for reducing blood loss at 8-12 weeks of gestation: a randomized double-blind placebo-controlled study.
Chitaishvili D; Asatiani T
Georgian Med News; 2007 Nov; (152):26-30. PubMed ID: 18175829
[TBL] [Abstract][Full Text] [Related]
35. A randomized double blind study of a new ready-for use prostaglandin gel (Org 2436) for cervical ripening prior to first trimester pregnancy termination.
Osmers R; Rath W; Conrad A; Kuhn W
Zentralbl Gynakol; 1990; 112(9):545-54. PubMed ID: 2378185
[TBL] [Abstract][Full Text] [Related]
36. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
Ramsey PS; Savage K; Lincoln T; Owen J
Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
[TBL] [Abstract][Full Text] [Related]
37. Oral versus vaginal misoprostol for induction of labor: a double-blind randomized controlled trial.
Fisher SA; Mackenzie VP; Davies GA
Am J Obstet Gynecol; 2001 Oct; 185(4):906-10. PubMed ID: 11641676
[TBL] [Abstract][Full Text] [Related]
38. Vaginal vs. sublingual misoprostol with mifepristone for cervical priming in second-trimester abortion by dilation and evacuation: a randomized clinical trial.
Carbonell JL; Gallego FG; Llorente MP; Bermudez SB; Sala ES; González LV; Texido CS
Contraception; 2007 Mar; 75(3):230-7. PubMed ID: 17303495
[TBL] [Abstract][Full Text] [Related]
39. Buccal misoprostol for cervical ripening prior to first trimester abortion.
Panchal HB; Godfrey EM; Patel A
Contraception; 2010 Feb; 81(2):161-4. PubMed ID: 20103456
[TBL] [Abstract][Full Text] [Related]
40. Prospective randomized clinical trial of inpatient cervical ripening with stepwise oral misoprostol vs vaginal misoprostol.
Colón I; Clawson K; Hunter K; Druzin ML; Taslimi MM
Am J Obstet Gynecol; 2005 Mar; 192(3):747-52. PubMed ID: 15746667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
